EdgarLookup

Childrens Place, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Childrens Place, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-7.3%
Profit Margin
Net income ÷ revenue
-13.2%
Return on Assets
Net income ÷ assets
-13.37x
Debt-to-Equity
Total liabilities ÷ equity
-12.8%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $1.21B Apr 10, 2026
FY2025 Feb 1, 2025 $1.39B Apr 10, 2026
FY2025 Feb 3, 2024 $1.60B Apr 10, 2026
FY2024 Jan 28, 2023 $1.71B Apr 17, 2025
FY2024 Jan 29, 2022 $1.92B May 6, 2024
FY2022 Jan 30, 2021 $1.52B Mar 28, 2023
FY2021 Feb 1, 2020 $1.87B Mar 25, 2022

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2018 Feb 2, 2019 $530.56M Mar 21, 2019
FY2018 Nov 3, 2018 $522.50M Mar 21, 2019
FY2018 Aug 4, 2018 $448.72M Mar 21, 2019
FY2018 May 5, 2018 $436.31M Mar 21, 2019
FY2018 Feb 3, 2018 $569.97M Mar 21, 2019
FY2018 Oct 28, 2017 $490.03M Mar 21, 2019
FY2018 Jul 29, 2017 $373.60M Mar 21, 2019
FY2018 Apr 29, 2017 $436.68M Mar 21, 2019
FY2017 Jan 28, 2017 $520.77M Mar 22, 2018
FY2017 Oct 29, 2016 $473.78M Mar 22, 2018

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $361.56M Apr 10, 2026
FY2025 Feb 1, 2025 $459.46M Apr 10, 2026
FY2025 Feb 3, 2024 $445.27M Apr 10, 2026
FY2024 Jan 28, 2023 $514.16M Apr 17, 2025
FY2024 Jan 29, 2022 $794.74M May 6, 2024
FY2020 Jan 30, 2021 $139.78M Mar 29, 2021
FY2020 Oct 31, 2020 $146.07M Mar 29, 2021
FY2020 Aug 1, 2020 $67.08M Mar 29, 2021
FY2020 May 2, 2020 ($19.67M) Mar 29, 2021
FY2020 Feb 1, 2020 $166.36M Mar 29, 2021

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 ($88.26M) Apr 10, 2026
FY2025 Feb 1, 2025 ($57.82M) Apr 10, 2026
FY2025 Feb 3, 2024 ($154.54M) Apr 10, 2026
FY2024 Jan 28, 2023 ($1.14M) Apr 17, 2025
FY2024 Jan 29, 2022 $187.17M May 6, 2024
FY2022 Jan 30, 2021 ($140.37M) Mar 28, 2023
FY2021 Feb 1, 2020 $73.30M Mar 25, 2022

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 ($57.21M) Apr 10, 2026
FY2025 Feb 1, 2025 ($13.70M) Apr 10, 2026
FY2025 Feb 3, 2024 ($83.80M) Apr 10, 2026
FY2024 Jan 28, 2023 ($1.53M) Apr 17, 2025
FY2024 Jan 29, 2022 $275.65M May 6, 2024
FY2020 Jan 30, 2021 $14.39M Mar 29, 2021
FY2020 Oct 31, 2020 $23.32M Mar 29, 2021
FY2020 Aug 1, 2020 ($64.48M) Mar 29, 2021
FY2020 May 2, 2020 ($173.14M) Mar 29, 2021
FY2020 Feb 1, 2020 $29.53M Mar 29, 2021

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $383.69M Apr 10, 2026
FY2025 Feb 1, 2025 $405.55M Apr 10, 2026
FY2025 Feb 3, 2024 $447.34M Apr 10, 2026
FY2024 Jan 28, 2023 $460.97M Apr 17, 2025
FY2024 Jan 29, 2022 $459.17M May 6, 2024
FY2020 Jan 30, 2021 $108.79M Mar 29, 2021
FY2020 Oct 31, 2020 $106.64M Mar 29, 2021
FY2020 Aug 1, 2020 $114.31M Mar 29, 2021
FY2020 May 2, 2020 $98.49M Mar 29, 2021
FY2020 Feb 1, 2020 $113.18M Mar 29, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $8.12M Apr 10, 2026
FY2025 Feb 1, 2025 ($117.59M) Apr 10, 2026
FY2025 Feb 3, 2024 $92.80M Apr 10, 2026
FY2024 Jan 28, 2023 ($8.22M) Apr 17, 2025
FY2024 Jan 29, 2022 $133.28M May 6, 2024
FY2022 Jan 30, 2021 ($35.72M) Mar 28, 2023
FY2021 Feb 1, 2020 $177.90M Mar 25, 2022
FY2020 Feb 2, 2019 $139.91M Mar 29, 2021
FY2019 Feb 3, 2018 $214.38M Mar 19, 2020
FY2018 Jan 28, 2017 $199.29M Mar 21, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $17.38M Apr 10, 2026
FY2025 Feb 1, 2025 $15.83M Apr 10, 2026
FY2025 Feb 3, 2024 $27.56M Apr 10, 2026
FY2024 Jan 28, 2023 $45.58M Apr 17, 2025
FY2024 Jan 29, 2022 $29.31M May 6, 2024
FY2022 Jan 30, 2021 $30.59M Mar 28, 2023
FY2021 Feb 1, 2020 $57.50M Mar 25, 2022

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $670.30M Apr 10, 2026
FY2025 Feb 1, 2025 $747.55M Apr 10, 2026
FY2024 Feb 3, 2024 $800.31M Apr 17, 2025
FY2024 Jan 28, 2023 $986.28M May 6, 2024
FY2022 Jan 29, 2022 $1.04B Mar 28, 2023
FY2021 Jan 30, 2021 $1.14B Mar 25, 2022
FY2020 Feb 1, 2020 $1.18B Mar 29, 2021
FY2019 Feb 2, 2019 $727.05M Mar 19, 2020
FY2018 Feb 3, 2018 $940.23M Mar 21, 2019
FY2017 Jan 28, 2017 $910.50M Mar 22, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $724.48M Apr 10, 2026
FY2025 Feb 1, 2025 $806.96M Apr 10, 2026
FY2024 Feb 3, 2024 $809.33M Apr 17, 2025
FY2024 Jan 28, 2023 $827.80M May 6, 2024
FY2022 Jan 29, 2022 $811.99M Mar 28, 2023
FY2021 Jan 30, 2021 $1.05B Mar 25, 2022
FY2020 Feb 1, 2020 $946.21M Mar 29, 2021
FY2019 Feb 2, 2019 $412.61M Mar 19, 2020
FY2018 Feb 3, 2018 $466.53M Mar 21, 2019
FY2017 Jan 28, 2017 $414.21M Mar 22, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 ($54.18M) Apr 10, 2026
FY2025 Feb 1, 2025 ($59.41M) Apr 10, 2026
FY2025 Feb 3, 2024 ($9.02M) Apr 10, 2026
FY2025 Jan 28, 2023 $158.48M Apr 10, 2026
FY2024 Jan 29, 2022 $225.47M Apr 17, 2025
FY2024 Jan 30, 2021 $93.38M May 6, 2024
FY2022 Feb 1, 2020 $235.19M Mar 28, 2023
FY2021 Feb 2, 2019 $314.44M Mar 25, 2022

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 ($280.95M) Apr 10, 2026
FY2025 Feb 1, 2025 ($192.68M) Apr 10, 2026
FY2024 Feb 3, 2024 ($134.87M) Apr 17, 2025
FY2024 Jan 28, 2023 $22.54M May 6, 2024
FY2022 Jan 29, 2022 $77.91M Mar 28, 2023
FY2021 Jan 30, 2021 ($42.79M) Mar 25, 2022
FY2020 Feb 1, 2020 $108.22M Mar 29, 2021
FY2019 Feb 2, 2019 $180.79M Mar 19, 2020
FY2018 Feb 3, 2018 $226.30M Mar 21, 2019
FY2017 Jan 28, 2017 $274.91M Mar 22, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 $5.49M Apr 10, 2026
FY2025 Feb 1, 2025 $5.35M Apr 10, 2026
FY2024 Feb 3, 2024 $13.64M Apr 17, 2025
FY2024 Jan 28, 2023 $16.69M May 6, 2024
FY2022 Jan 29, 2022 $54.79M Mar 28, 2023
FY2021 Jan 30, 2021 $63.55M Mar 25, 2022
FY2020 Feb 1, 2020 $68.49M Mar 29, 2021
FY2020 Feb 2, 2019 $69.14M Mar 29, 2021
FY2020 Feb 3, 2018 $244.52M Mar 29, 2021
FY2019 Jan 28, 2017 $193.71M Mar 19, 2020

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2024 Feb 3, 2024 $49.82M May 6, 2024
FY2024 Jan 28, 2023 $49.75M May 6, 2024
FY2022 Jan 29, 2022 $49.69M Mar 28, 2023
FY2021 Jan 30, 2021 $75.35M Mar 25, 2022
FY2011 Jul 31, 2008 $85.00M Mar 23, 2012

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 (4) Apr 10, 2026
FY2025 Feb 1, 2025 (4) Apr 10, 2026
FY2025 Feb 3, 2024 (12) Apr 10, 2026
FY2024 Jan 28, 2023 0 Apr 17, 2025
FY2024 Jan 29, 2022 12 May 6, 2024
FY2022 Jan 30, 2021 (9) Mar 28, 2023
FY2021 Feb 1, 2020 4 Mar 25, 2022
FY2012 Feb 2, 2013 2 Mar 28, 2013
FY2012 Jan 28, 2012 2 Mar 28, 2013
FY2012 Jan 29, 2011 2 Mar 28, 2013

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 (4) Apr 10, 2026
FY2025 Feb 1, 2025 (4) Apr 10, 2026
FY2025 Feb 3, 2024 (12) Apr 10, 2026
FY2024 Jan 28, 2023 0 Apr 17, 2025
FY2024 Jan 29, 2022 12 May 6, 2024
FY2022 Jan 30, 2021 (9) Mar 28, 2023
FY2021 Feb 1, 2020 4 Mar 25, 2022
FY2012 Feb 2, 2013 2 Mar 28, 2013
FY2012 Jan 28, 2012 2 Mar 28, 2013
FY2012 Jan 29, 2011 2 Mar 28, 2013

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Jan 31, 2026 22.17M Apr 10, 2026
FY2025 Feb 1, 2025 12.78M Apr 10, 2026
FY2024 Feb 3, 2024 12.53M Apr 17, 2025
FY2024 Jan 28, 2023 12.23M May 6, 2024
FY2022 Jan 29, 2022 13.90M Mar 28, 2023
FY2021 Jan 30, 2021 14.58M Mar 25, 2022
FY2020 Feb 1, 2020 14.71M Mar 29, 2021
FY2019 Feb 2, 2019 15.83M Mar 19, 2020
FY2018 Feb 3, 2018 17.21M Mar 21, 2019
FY2017 Jan 28, 2017 17.72M Mar 22, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2024 Feb 1, 2025 $1.69M Apr 17, 2025
FY2024 Feb 3, 2024 $0 Apr 17, 2025
FY2024 Jan 28, 2023 $0 Apr 17, 2025
FY2021 Jan 29, 2022 $0 Mar 25, 2022
FY2021 Jan 30, 2021 $0 Mar 25, 2022
FY2021 Feb 1, 2020 $34.93M Mar 25, 2022
FY2020 Feb 2, 2019 $33.04M Mar 29, 2021
FY2019 Feb 3, 2018 $28.10M Mar 19, 2020
FY2018 Jan 28, 2017 $14.79M Mar 21, 2019
FY2017 Jan 30, 2016 $12.22M Mar 22, 2018